Bright Minds Biosciences Inc. (NASDAQ:DRUG – Get Free Report) was the target of a significant increase in short interest in October. As of October 15th, there was short interest totalling 1,170,000 shares, an increase of 1,274.9% from the September 30th total of 85,100 shares. Based on an average daily volume of 2,890,000 shares, the days-to-cover ratio is currently 0.4 days. Currently, 38.2% of the company’s shares are short sold.
Bright Minds Biosciences Stock Performance
Shares of Bright Minds Biosciences stock opened at $48.94 on Friday. Bright Minds Biosciences has a 52 week low of $0.93 and a 52 week high of $79.02. The stock has a 50 day moving average price of $8.51 and a two-hundred day moving average price of $3.69. The stock has a market capitalization of $217.00 million, a PE ratio of -48.46 and a beta of 1.56.
Bright Minds Biosciences (NASDAQ:DRUG – Get Free Report) last announced its quarterly earnings data on Wednesday, August 14th. The company reported $0.04 EPS for the quarter.
Insiders Place Their Bets
Bright Minds Biosciences Company Profile
Bright Minds Biosciences Inc, a biotechnology company, develops therapeutics to improve the lives of patients with severe and life-altering diseases in the United States. Its portfolio of selective 5-HT receptor agonists includes 5-HT2C, 5-HT2A, and 5-HT2C/A for the treatment of epilepsy, pain, and neuropsychiatry; and BMB-101 which completes phase 1 trial for undisclosed seizure disorder.
Featured Stories
- Five stocks we like better than Bright Minds Biosciences
- Want to Profit on the Downtrend? Downtrends, Explained.
- Real Estate Sector Outperforms: 3 Stocks to Gain Exposure
- Why is the Ex-Dividend Date Significant to Investors?
- Lam Research Proves Analysts Wrong with a Strong Earnings Report
- How to Find Undervalued Stocks
- PureCycle: Up 250% in 2024 – Is This Materials Stock Still a Buy?
Receive News & Ratings for Bright Minds Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bright Minds Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.